Spectral AI to Participate in Benzinga’s “AI Unleashed: Exploring the Possibilities” Virtual Event
Spectral AI (Nasdaq: MDAI), an AI company specializing in medical diagnostics for wound care, announced its participation in Benzinga’s “AI Unleashed: Exploring the Possibilities” virtual event on May 30, 2024. CEO Peter M. Carlson will represent the company in a fireside chat starting at 11:25 am ET. The event will be live-streamed and accessible through the company's investor portal. This event serves as a platform for Spectral AI to showcase its advancements and future prospects in AI-driven medical diagnostics.
- Spectral AI's participation in a high-profile event like Benzinga’s 'AI Unleashed' increases the company's visibility in the AI and medical diagnostics sectors.
- CEO Peter M. Carlson's involvement offers a leadership perspective on the company's innovations and strategic direction.
- The event provides an opportunity to attract potential investors and partners by showcasing Spectral AI's capabilities and future plans.
- The press release lacks specific financial data, leaving investors without concrete information on recent performance or projections.
- Participation in events, while positive for visibility, does not guarantee immediate financial benefits or stock performance improvements.
DALLAS, May 28, 2024 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced that Peter M. Carlson, Chief Executive Officer of Spectral AI, is scheduled to participate in a fireside chat at Benzinga’s “AI Unleashed: Exploring the Possibilities” virtual event, taking place on May 30, 2024.
The fireside chat will begin at 11:25 am ET and can be accessed live here. Interested parties may also access the live and archived webcast of the event by visiting the Investors section of Spectral AI’s website at https://investors.spectral-ai.com/news-events/events.
About Spectral AI
Spectral AI, Inc. is a Dallas-based predictive AI company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, with initial applications involving patients with burns and diabetic foot ulcers. The Company is working to revolutionize the management of wound care by “Seeing the Unknown®” with its DeepView System. DeepView is a predictive medical device that offers clinicians an objective and immediate assessment of a wound’s healing potential prior to treatment or other medical intervention. With algorithm-driven results and a goal of exceeding the current standard of care in the future, DeepView is expected to provide faster and more accurate treatment insight towards value care by improving patient outcomes and reducing healthcare costs. For more information about DeepView, visit www.spectral-ai.com.
Forward-Looking Statements
Certain statements made in this release are “forward looking statements” within the meaning of the “safe harbor” provisions of the United States Private Securities Litigation Reform Act of 1995, including statements regarding the Company’s strategy, plans, objectives, initiatives and financial outlook. When used in this press release, the words “estimates,” “projected,” “expects,” “anticipates,” “forecasts,” “plans,” “intends,” “believes,” “seeks,” “may,” “will,” “should,” “future,” “propose” and variations of these words or similar expressions (or the negative versions of such words or expressions) are intended to identify forward-looking statements.
These forward-looking statements are not guarantees of future performance, conditions or results, and involve a number of known and unknown risks, uncertainties, assumptions and other important factors, many of which are outside Company’s control, that could cause actual results or outcomes to differ materially from those discussed in the forward-looking statements. As such, readers are cautioned not to place undue reliance on any forward-looking statements.
Investors should carefully consider the foregoing factors and the other risks and uncertainties described in the “Risk Factors” sections of the Company’s filings with the SEC, including the Registration Statement and the other documents filed by the Company. These filings identify and address other important risks and uncertainties that could cause actual events and results to differ materially from those contained in the forward-looking statements.
| Investors: | ||
| The Equity Group Devin Sullivan Managing Director dsullivan@equityny.com | Conor Rodriguez Analyst crodriguez@equityny.com | |
| Media: | ||
| Russo Partners David Schull Russo Partners (858) 717-2310 david.schull@russopartnersllc.com | ||
FAQ
What is the date of Spectral AI's participation in Benzinga’s 'AI Unleashed' event?
Who will represent Spectral AI at the Benzinga virtual event?
At what time will Spectral AI's fireside chat take place during the Benzinga event?
How can I access the live webcast of Spectral AI's fireside chat?
What is the focus of Spectral AI's participation in the event?
